Endo Inc. (NDOI)
OTCMKTS
· Delayed Price · Currency is USD
25.30
-2.95 (-10.44%)
Mar 13, 2025, 4:00 PM EST
Endo Inc. Revenue
In the year 2024, Endo Inc. had annual revenue of $1.18B, down -41.43%. Endo Inc. had revenue of $467.50M in the quarter ending December 31, 2024, a decrease of -6.07%.
Revenue
1.18B
Revenue Growth
-41.43%
P/S Ratio
1.64
Revenue / Employee
401.97K
Employees
2,931
Market Cap
1.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.18B | -833.35M | -41.43% |
| Dec 31, 2023 | 2.01B | -307.36M | -13.25% |
| Dec 31, 2022 | 2.32B | -674.33M | -22.53% |
| Dec 31, 2021 | 2.99B | 90.13M | 3.10% |
| Dec 31, 2020 | 2.90B | -11.29M | -0.39% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 16.04M |
| Veradigm | 1.53B |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 43.26M |
| BioStem Technologies | 210.49M |
| Longduoduo Company | 6.01M |
Endo Inc. News
- 9 hours ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Endo, Inc. - PRNewsWire
- 10 hours ago - $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Endo, Inc. - NDOI - PRNewsWire
- 16 hours ago - NDOI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Endo, Inc. Is Fair to Shareholders - Business Wire
- 17 hours ago - Shareholder Alert: The Ademi Firm Investigates Whether Endo, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire
- 18 hours ago - Mallinckrodt, Endo Merger to Create Diversified Pharmaceuticals Firm - WSJ
- 18 hours ago - Mallinckrodt and Endo plan merger as they look to recover from opioid litigation - Market Watch
- 19 hours ago - Drugmakers Mallinckrodt and Endo to merge in nearly $7 billion deal - Reuters
- 19 hours ago - Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results - PRNewsWire